|
SCD expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.73294711913741E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.67029999831314E-08 |
| Normal-vs-Stage2 |
9.184700E-03 |
| Normal-vs-Stage3 |
1.559900E-03 |
| Normal-vs-Stage4 |
6.412300E-02 |
| Stage1-vs-Stage2 |
8.082300E-02 |
| Stage1-vs-Stage3 |
1.745380E-01 |
| Stage1-vs-Stage4 |
5.822400E-01 |
| Stage2-vs-Stage3 |
3.128000E-01 |
| Stage2-vs-Stage4 |
1.928640E-01 |
| Stage3-vs-Stage4 |
6.334400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.01017022208816E-12 |
| Normal-vs-AfricanAmerican |
1.57382999999012E-05 |
| Normal-vs-Asian |
2.478800E-01 |
| Caucasian-vs-AfricanAmerican |
6.081000E-01 |
| Caucasian-vs-Asian |
5.811800E-01 |
| AfricanAmerican-vs-Asian |
5.345200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.76365605347928E-12 |
| Normal-vs-Female |
3.99700000000003E-05 |
| Male-vs-Female |
5.866800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.73760000000379E-05 |
| Normal-vs-Extreme_Weight |
3.52010000037595E-08 |
| Normal-vs-Obese |
2.30229999997889E-06 |
| Normal-vs-Extreme_Obese |
1.625360E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.104600E-01 |
| Normal_Weight-vs-Obese |
5.076000E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.183600E-03 |
| Extreme_Weight-vs-Obese |
2.989200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.203800E-04 |
| Obese-vs-Extreme_Obese |
5.236000E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.217600E-01 |
| Normal-vs-Age(41-60Yrs) |
5.68159996827688E-09 |
| Normal-vs-Age(61-80Yrs) |
4.76329975462875E-10 |
| Normal-vs-Age(81-100Yrs) |
5.536900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.223200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.039600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.832400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.993000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.548400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.172800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.13950004566288E-09 |
| Normal-VS-Type2 PRCC |
2.50109999377912E-09 |
| Normal-VS-KIRP CIMP |
5.026900E-04 |
| Normal-VS-Unclassified PRCC |
4.56250000002711E-06 |
| Type1 PRCC-VS-Type2 PRCC |
3.151200E-04 |
| Type1 PRCC-VS-KIRP CIMP |
1.62436730732907E-12 |
| Type1 PRCC-VS-Unclassified PRCC |
8.127900E-02 |
| Type2 PRCC-VS-KIRP CIMP |
7.90134624395478E-12 |
| Type2 PRCC-VS-Unclassified PRCC |
5.921900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.73579999765516E-08 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.79319999999273E-05 |
| Normal-vs-N1 |
1.485940E-02 |
| Normal-vs-N2 |
1.311210E-01 |
| N0-vs-N1 |
4.789000E-01 |
| N0-vs-N2 |
7.074000E-01 |
| N1-vs-N2 |
9.601000E-01 |
|
|
